Jyong Biotech MENS
NASDAQ MENS
$1.77 +0.03 (+1.72%)
At close: Oct 23, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Cash & Current Investments (2024 - 2025)

Updated

Jyong Biotech (MENS) recorded Cash & Current Investments of $1.18 million in the quarter ended Dec 31, 2025, compared with $98,000 a year earlier.

Analysis

Jyong Biotech (MENS) Cash & Current Investments (2024 - 2025) Analysis & Trends

  • Across earlier years, Cash & Current Investments came in at $98,000 in the year ended Dec 31, 2024 (-95.7%) and $2.27 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Jyong Biotech 134.57 Mn 133.39 Mn - 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.18 Mn
Jun 30, 2025 17.01 Mn
Dec 31, 2024 101,000.00
API Access

Jyong Biotech Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=MENS&period=max&api_key=YOUR_API_KEY